Impact of Administration Time and Kv7 Subchannels on the Cardioprotective Efficacy of Kv7 Channel Inhibition.

Drug Design, Development and Therapy
Jan HansenHans Erik Bøtker

Abstract

The mechanism of cardioprotection by Kv7.1-5 (KCNQ1-5) channels inhibition by XE991 is unclear. We examined the impact of administration time on the cardioprotective efficacy of XE991, the involvement of key pro-survival kinases, and the importance of the Kv7 subchannels. Isolated perfused rat hearts were divided into five groups: 1) vehicle, 2) pre-, 3) post- or 4) pre- and post-ischemic administration of XE991 or 5) chromanol 293B (Kv7.1 inhibitor) followed by infarct size quantification. HL-1 cells undergoing simulated ischemia/reperfusion were exposed to either a) vehicle, b) pre-, c) per-, d) post-ischemic administration of XE991 or pre-, per- and post-ischemic administration of e) XE991, f) Chromanol 293B or g) HMR1556 (Kv7.1 inhibitor). HL-1 cell injury was evaluated by propidium iodide/Hoechst staining. Pro-survival kinase activation of Akt, Erk and STAT3 in XE991-mediated HL-1 cell protection was evaluated using phosphokinase inhibitors. Kv7 subtype expression was examined by RT-PCR and qPCR. XE991, but not Chromanol 293B, reduced infarct size and improved hemodynamic recovery in all isolated heart groups. XE991 protected HL-1 cells when administered during simulated ischemia. Minor activation of the survival kinases w...Continue Reading

References

Jan 1, 1995·British Heart Journal·P D HighamR W Campbell
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·W C ClaycombN J Izzo
Mar 14, 2001·American Journal of Physiology. Cell Physiology·R SøgaardB S Jensen
Mar 12, 2004·Biochemical and Biophysical Research Communications·Anne K JonassenMichael N Sack
Sep 11, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Derek J HausenloyDerek M Yellon
Jun 2, 2007·Heart Failure Reviews·Derek J Hausenloy, Derek M Yellon
Aug 19, 2008·Lancet·Harvey D White, Derek P Chew
Feb 17, 2009·Cardiovascular Research·Derek J Hausenloy, Derek M Yellon
Apr 14, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Jason N Peart, John P Headrick
Jun 22, 2011·Nature Reviews. Cardiology·Derek J Hausenloy, Derek M Yellon
Oct 23, 2012·Analytical Biochemistry·Anne GürtlerAnton Posch
Oct 2, 2013·Hypertension·Saereh KhanamiriSøren-Peter Olesen
Oct 12, 2013·British Journal of Pharmacology·E R HedegaardU Simonsen
Dec 10, 2013·International Journal of Cardiology·Jonas Agerlund PovlsenHans Erik Bøtker
Dec 6, 2014·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Sewon LeeMichael A Hill
Jul 15, 2015·Scandinavian Cardiovascular Journal : SCJ·Erik HelgelandAnne K Jonassen
Feb 13, 2016·The Journal of Pharmacology and Experimental Therapeutics·Elise R HedegaardHans Erik Bøtker
Mar 10, 2016·Cardiovascular Research·Zhaoyang HuGeoffrey W Abbott
May 18, 2016·Pharmacology & Therapeutics·Jennifer M Haick, Kenneth L Byron
Jan 10, 2019·Journal of the American College of Cardiology·Sean M DavidsonUNKNOWN CARDIOPROTECTION COST Action (CA16225)
Nov 25, 2019·European Journal of Pharmacology·Krestine Kjeldsen CorydonUlf Simonsen

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
scraping
protein assay
electrophoresis
reverse transcription PCR
PCR

Software Mentioned

GraphPad PRISM
imageJ
GraphPad
Notocord Hem

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.